Aveanna Healthcare Holdings has delivered a very large 3 year return, yet the valuation checks still suggest the stock leans cheap overall. With sentiment shaped by both a strong share price run and fresh news around a secondary offering and higher long term growth ambitions, investors are asking whether the current price still reflects a discount. Aveanna Healthcare Holdings has returned about 8x over the last 3 years, which puts extra focus on whether that pace is now fully reflected in...

Preferred payer volumes and state rate hikes drove 13.7% revenue growth.

Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred payers support expansion.

Aveanna Healthcare Holdings Inc (AVAH) reports a 13.7% revenue increase and raises full-year 2026 outlook, driven by robust segment performance and strategic payer agreements.

Moby summary of Aveanna Healthcare Holdings Inc.'s Q2 2026 earnings call

Aveanna Healthcare (NASDAQ:AVAH) reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three operating divisions, improved reimbursement rates, increased volumes and operational efficiencies. The company also raised its full-year outlook and updated its long-term

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna (AVAH) delivered earnings and revenue surprises of +29.41% and +3.62%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on earnings.

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

Aveanna Healthcare Holdings (NasdaqGS: AVAH) announced the resignation of independent director Dr. Erica Schwartz from its Board following her appointment as Director of the U.S. Centers for Disease Control and Prevention. Dr. Schwartz also stepped down as Chair of Aveanna's Clinical Quality Committee, creating a vacancy in a key oversight role. The company highlighted this as a material leadership change and a high profile public health appointment connected to its boardroom. For readers...

LifeStance Health (LFST) delivered earnings and revenue surprises of +100.00% and +5.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The Pennant Group (PNTG) delivered earnings and revenue surprises of +9.09% and +3.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

AVAH vs. CHE: Which Stock Is the Better Value Option?

Investors might want to start buying best-in-class, cheap stocks trading under $10 a share as the market soars to start August.

BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.

Bassett Furniture, Aveanna Healthcare and Integra LifeSciences are highlighted as potential breakout stocks using support and resistance levels ahead of August.

Breakout stocks BSET, AVAH and IART are trading near 52-week highs after passing technical screens. See why they could outperform in August.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how Bioventus (BVS) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Is it a good or bad thing when a stock experiences a golden cross technical event?

Aveanna Healthcare Holdings stock has delivered a very large 3 year return while valuation checks still indicate the shares trade at a discount, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model and market multiples both pointing to undervaluation. Over the last 3 years, Aveanna Healthcare Holdings has returned about 4.6x, which raises the question of whether the current share price leaves further room when compared with fundamentals. For a company like Aveanna...

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) is one of the best future stocks to buy under $10. On June 2, Aveanna Healthcare Holdings announced the completion of its acquisition of Family First Homecare, a pediatric home care provider with 27 locations across 7 states. The $175.5 million cash transaction is designed to expand Aveanna’s specialized care […]

Analyst James Early highlights Aveanna Healthcare, Genworth Financial and eGain as profitable small-cap stocks under $10, citing fundamentals over hype amid a big tech pullback.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.